Regulation of gene expression
Also known as: epigenetics, DNA methylation, histone acetylation, microRNA, imprinting, X-inactivation, transcription factors
The control of when, where and how much each gene is expressed — at the level of chromatin, transcription, RNA processing, translation and protein stability — which makes cells with identical DNA different.
Overview
Chromatin level (epigenetic): histone acetylation by HATs loosens chromatin and favours transcription, deacetylation by HDACs condenses it; histone methylation can activate or repress depending on the residue. DNA methylation of cytosines in CpG islands of promoters (by DNMTs) silences genes stably through cell divisions. These marks underlie X-inactivation (XIST RNA coats the inactive X) and genomic imprinting (expression of only the maternal or paternal allele).
Transcriptional level: sequence-specific transcription factors (zinc-finger, helix-turn-helix, leucine-zipper, helix-loop-helix families) bind promoters and enhancers and recruit or block co-activators and the transcription machinery. Combinations of factors define cell identity (e.g. MyoD in muscle). Signals regulate transcription factors by phosphorylation, ligand binding (nuclear hormone receptors) or controlled nuclear entry (NF-κB, SMADs, STATs).
Post-transcriptional level: alternative splicing, regulated mRNA stability and localisation, microRNAs (≈22-nucleotide RNAs that guide the RISC complex to block translation or degrade target mRNAs) and translational control (e.g. iron-responsive elements: low iron increases ferritin translation and stabilises transferrin-receptor mRNA). Post-translational level: phosphorylation, proteolytic activation and ubiquitin-mediated destruction. (In bacteria, genes are often grouped in co-regulated operons such as the lac operon — absent in humans.)
Parts & subdivisions
- Chromatin remodelling and histone modificationHATs/HDACs, methyltransferases, ATP-dependent remodellers.
- DNA methylationCpG methylation silences promoters; maintained by DNMT1.
- Transcription factorsActivators and repressors acting via enhancers/silencers.
- MicroRNAsPost-transcriptional silencing via RISC.
Function
- Establishes and maintains cell identity during differentiation.
- Allows rapid responses to hormones, nutrients and stress.
- Balances gene dosage (X-inactivation).
Clinical significance
Imprinting disorders
Deletion of 15q11–q13 on the paternal chromosome (or maternal uniparental disomy) causes Prader–Willi syndrome (hyperphagia, obesity, hypotonia, hypogonadism); loss of the maternal copy (UBE3A) causes Angelman syndrome (seizures, ataxia, inappropriate laughter).
Fragile X syndrome
Expansion of CGG repeats (> 200) in FMR1 causes promoter hypermethylation and silencing: intellectual disability, long face, large ears, macro-orchidism.
Epigenetic drugs
DNMT inhibitors (azacitidine, decitabine) for myelodysplastic syndromes; HDAC inhibitors (vorinostat) for cutaneous T-cell lymphoma.
Compiled from standard anatomy and physiology references — see the Cells & Tissues sources. For education only; not medical advice.